NCT00847925View on ClinicalTrials.gov

Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Cicatrix
Interventions
DRUG

Avotermin (RN1001)

100ul/linear cm of wound. Dosed before surgery and 24h later

Trial Locations (1)

M13 9XX

Renovo CTU, Manchester

All Listed Sponsors
lead

Renovo

INDUSTRY

NCT00847925 - Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects | Biotech Hunter | Biotech Hunter